CEPI (Coalition for Epidemic Preparedness Innovations) published an explainer from its biosecurity team detailing the role of biosecurity and biosafety in delivering CEPI 3.0 and the 100 Days Mission.
Published
Signal category
Research & Knowledge
Quote
“A really useful explainer from CEPI’s biosecurity team on the role biosecurity and biosafety will play in delivering CEPI 3.0 and the 100 Days Mission.”
— Kaleem Ullah Khan|CEPI (Coalition for Epidemic Preparedness Innovations) team
Company
CEPI (Coalition for Epidemic Preparedness Innovations)
We want to stop future epidemics by developing new vaccines for a safer world.
- Industry
- Research Services
- Location
- Oslo, NO
- Company size
- 541 employees
CEPI is an innovative partnership between public, private, philanthropic and civil organisations. Its mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need. Central to CEPI’s pandemic-beating plan is the ‘100 Days Mission’ – its goal to develop safe, effective and accessible vaccines against new threats in just 100 days. CEPI is seeking $2.5 billion to execute CEPI 3.0, its 2027-2031 strategy, which will systematically reduce the likelihood, impact and cost of epidemics and pandemics by driving the 100 Days Mission towards an operational reality. Learn more at CEPI.net.
Founded 2017